• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌心包炎与病毒性或特发性急性心包炎

Myopericarditis versus viral or idiopathic acute pericarditis.

作者信息

Imazio M, Cecchi E, Demichelis B, Chinaglia A, Ierna S, Demarie D, Ghisio A, Pomari F, Belli R, Trinchero R

机构信息

Cardiology Department, Maria Vittoria Hospital, Via Cibrario 72, 10141 Torino, Italy.

出版信息

Heart. 2008 Apr;94(4):498-501. doi: 10.1136/hrt.2006.104067. Epub 2007 Jun 17.

DOI:10.1136/hrt.2006.104067
PMID:17575329
Abstract

OBJECTIVE

To investigate the relative incidence, clinical presentation and prognosis of myopericarditis among patients with idiopathic or viral acute pericarditis.

DESIGN

Prospective observational clinical cohort study.

SETTING

Two general hospitals from an urban area of 220 000 inhabitants.

PATIENTS

274 consecutive cases of idiopathic or viral acute pericarditis between January 2001 and June 2005.

MAIN OUTCOME MEASURES

Relative prevalence of myopericarditis. Clinical features at presentation including echocardiographic data (ejection fraction (EF), wall motion score index (WMSI)) and follow-up data at 12 months including complications, results of echocardiography, electrocardiography and treadmill testing.

RESULTS

Myopericarditis was recorded in 40/274 (14.6%) consecutive patients. At presentation, the following clinical features were independently associated with myopericarditis: arrhythmias (odds ratio (OR) = 17.6, 95% confidence interval (CI) 5.7 to 54.1; p<0.001), male gender (OR = 6.4, 95% CI 2.3 to 18.4; p = 0.01), age <40 years (OR = 6.1, 95% CI 2.2 to 16.9; p = 0.01), ST elevation (OR = 5.4, 95% CI 1.4 to 20.5; p = 0.013) and a recent febrile syndrome (OR = 2.8, 95% CI 1.1 to 7.7; p = 0.044). After 12 months' follow-up an increase of EF (basal EF 49.6 (5.1)% vs 12-month EF 59.1 (4.6)%; p<0.001) and decrease of WMSI (basal WMSI 1.19 (0.27) vs 12-month WMSI 1.02 (0.09); p<0.001) were recorded in patients with myopericarditis, with a normalisation of echocardiography, electrocardiography and treadmill testing in 98% of cases. Use of heparin or other anticoagulants (OR = 1.1, 95% CI 0.3 to 3.5; p = 0.918) and myopericarditis (OR = 2.3, 95% CI 0.7 to 7.6; p = 0.187) was not associated with an increased risk of cardiac tamponade or recurrences.

CONCLUSIONS

Myopericarditis is relatively common and shows a benign evolution also in spontaneous cases not related to vaccination.

摘要

目的

研究特发性或病毒性急性心包炎患者中心肌心包炎的相对发病率、临床表现及预后。

设计

前瞻性观察性临床队列研究。

地点

来自一个拥有22万居民的市区的两家综合医院。

患者

2001年1月至2005年6月期间连续收治的274例特发性或病毒性急性心包炎患者。

主要观察指标

心肌心包炎的相对患病率。就诊时的临床特征,包括超声心动图数据(射血分数(EF)、室壁运动评分指数(WMSI))以及12个月时的随访数据,包括并发症、超声心动图、心电图及平板运动试验结果。

结果

在274例连续患者中有40例(14.6%)被记录为心肌心包炎。就诊时,以下临床特征与心肌心包炎独立相关:心律失常(比值比(OR)=17.6,95%置信区间(CI)5.7至54.1;p<0.001)、男性(OR = 6.4,95%CI 2.3至18.4;p = 0.01)、年龄<40岁(OR = 6.1,95%CI 2.2至16.9;p = 0.01)、ST段抬高(OR = 5.4,95%CI 1.4至20.5;p = 0.013)以及近期发热综合征(OR = 2.8,95%CI 1.1至7.7;p = 0.044)。经过12个月的随访,心肌心包炎患者的EF升高(基础EF 49.6(5.1)% vs 12个月时EF 59.1(4.6)%;p<0.001),WMSI降低(基础WMSI 1.19(0.27)vs 12个月时WMSI 1.02(0.09);p<0.001),98%的病例超声心动图、心电图及平板运动试验恢复正常。使用肝素或其他抗凝剂(OR = 1.1,95%CI 0.3至3.5;p = 0.918)与心肌心包炎(OR = 2.3,95%CI 0.7至7.6;p = 0.187)与心脏压塞或复发风险增加无关。

结论

心肌心包炎相对常见,且在与疫苗接种无关的自发病例中也呈现良性演变。

相似文献

1
Myopericarditis versus viral or idiopathic acute pericarditis.心肌心包炎与病毒性或特发性急性心包炎
Heart. 2008 Apr;94(4):498-501. doi: 10.1136/hrt.2006.104067. Epub 2007 Jun 17.
2
Diagnostic yield of extensive infectious panel testing in acute pericarditis.急性心包炎广泛感染检测组套的诊断率
Cardiology. 2011;119(3):134-9. doi: 10.1159/000330928. Epub 2011 Sep 21.
3
Can troponin elevation predict worse prognosis in patients with acute pericarditis?肌钙蛋白升高能否预测急性心包炎患者的预后更差?
Ann Cardiol Angeiol (Paris). 2010 Feb;59(1):1-7. doi: 10.1016/j.ancard.2009.07.009. Epub 2009 Aug 13.
4
Good prognosis for pericarditis with and without myocardial involvement: results from a multicenter, prospective cohort study.心包炎伴或不伴心肌受累的良好预后:多中心前瞻性队列研究结果。
Circulation. 2013 Jul 2;128(1):42-9. doi: 10.1161/CIRCULATIONAHA.113.001531. Epub 2013 May 24.
5
Myopericarditis: Etiology, management, and prognosis.心肌心包炎:病因、管理与预后。
Int J Cardiol. 2008 Jun 23;127(1):17-26. doi: 10.1016/j.ijcard.2007.10.053. Epub 2008 Jan 24.
6
Indicators of poor prognosis of acute pericarditis.急性心包炎预后不良的指标。
Circulation. 2007 May 29;115(21):2739-44. doi: 10.1161/CIRCULATIONAHA.106.662114. Epub 2007 May 14.
7
[Varicella zoster myopericarditis in an immunocompetent adult].[免疫功能正常成年人的水痘带状疱疹性心肌心包炎]
Acta Med Croatica. 2009 Oct;63(4):325-7.
8
Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial.秋水仙碱联合急性心包炎传统疗法:急性心包炎秋水仙碱治疗(COPE)试验结果
Circulation. 2005 Sep 27;112(13):2012-6. doi: 10.1161/CIRCULATIONAHA.105.542738.
9
[Diagnosis and course of myocarditis: a survey in the medical clinics of Zurich University Hospital 1980 to 1998].[心肌炎的诊断与病程:苏黎世大学医院内科诊所1980年至1998年的一项调查]
Schweiz Med Wochenschr. 2000 Sep 9;130(36):1265-71.
10
[Ventricular extrasystole as manifestation of viral myocarditis and myopericarditis in young patients].[室性期前收缩作为年轻患者病毒性心肌炎和心肌心包炎的表现]
Ter Arkh. 2007;79(12):28-34.

引用本文的文献

1
Understanding Hemodialysis-Associated Pericarditis: Causes, Symptoms, and Management Strategies.了解血液透析相关心包炎:病因、症状及管理策略。
J Clin Med. 2025 Aug 22;14(17):5944. doi: 10.3390/jcm14175944.
2
Clonal Hematopoiesis and Risk of New-Onset Myocarditis and Pericarditis.克隆性造血与新发心肌炎和心包炎的风险
JAMA Cardiol. 2025 Aug 30. doi: 10.1001/jamacardio.2025.3369.
3
Salmonellosis-Induced Pericarditis and Pericardial Effusion: A Case Report and Literature Review.沙门氏菌病诱发的心包炎和心包积液:一例病例报告及文献综述
Cureus. 2025 Feb 10;17(2):e78825. doi: 10.7759/cureus.78825. eCollection 2025 Feb.
4
Clinical relevance of HRR (hemoglobin to RDW) and RAR (RDW to albumin) in pericarditis.血红蛋白与红细胞分布宽度比值(HRR)和红细胞分布宽度与白蛋白比值(RAR)在心包炎中的临床相关性。
Biomark Med. 2025 Mar;19(6):197-204. doi: 10.1080/17520363.2025.2471743. Epub 2025 Feb 27.
5
Imaging and Circulating Biomarker-Defined Cardiac Pathology in Pulmonary Tuberculosis: A Systematic Review.影像学与循环生物标志物在肺结核心脏病变中的应用:一项系统综述。
Glob Heart. 2024 Nov 8;19(1):84. doi: 10.5334/gh.1369. eCollection 2024.
6
Genetic variants in patients with recurrent pericarditis.复发性心包炎患者的遗传变异。
J Cardiovasc Med (Hagerstown). 2024 Nov 1;25(11):799-804. doi: 10.2459/JCM.0000000000001669. Epub 2024 Sep 17.
7
Advances in the Multimodality Imaging and Management of Recurrent Pericarditis: A Contemporary Review.复发性心包炎的多模态成像与管理进展:当代综述
Curr Cardiol Rep. 2024 Dec;26(12):1359-1375. doi: 10.1007/s11886-024-02133-3. Epub 2024 Sep 20.
8
Novel Pathophysiological, Diagnostic and Therapeutic Concepts in Acute and Recurrent Pericarditis.急性和复发性心包炎的新型病理生理、诊断和治疗概念
Rev Cardiovasc Med. 2023 Mar 3;24(3):77. doi: 10.31083/j.rcm2403077. eCollection 2023 Mar.
9
Incidence and Prevalence of Cardiac Arrhythmias in Pericardial Syndromes.心包综合征中心律失常的发病率和患病率
Rev Cardiovasc Med. 2022 Oct 17;23(10):347. doi: 10.31083/j.rcm2310347. eCollection 2022 Oct.
10
JYNNEOS Vaccine Safety Surveillance During the 2022 Mpox Outbreak Using the Vaccine Adverse Event Reporting System and V-safe, United States, 2022 to 2023.2022年至2023年美国利用疫苗不良事件报告系统和V-safe对2022年猴痘疫情期间JYNNEOS疫苗安全性的监测
Sex Transm Dis. 2024 Aug 1;51(8):509-515. doi: 10.1097/OLQ.0000000000001978. Epub 2024 Apr 17.